tiprankstipranks
Trending News
More News >
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (HK:2502)
:2502
Hong Kong Market
Advertisement

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) AI Stock Analysis

Compare
0 Followers

Top Page

HK:2502

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H

(2502)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 4o)
Rating:52Neutral
Price Target:
HK$0.50
▲(25.00% Upside)
The overall stock score reflects mixed financial performance and bearish technical indicators. While revenue growth is positive, profitability issues and negative earnings weigh heavily. The stock's high dividend yield offers some appeal, but technical analysis suggests caution due to bearish momentum.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H (2502) vs. iShares MSCI Hong Kong ETF (EWH)

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Business Overview & Revenue Model

Company DescriptionHenan Jinyuan Hydrogenated Chemicals Co., Ltd. engages in the processing, production, distribution, and sale of hydrogenated benzene-based chemicals and energy products in the People's Republic of China. Its hydrogenated benzene-based chemicals include pure benzene, toluene, and xylene; and energy products comprising liquefied natural gas (LNG) and coal gas. The company is also involved in the trading and retail of LNG and oil products; operation of oil and gas stations; steam services; and provision of multimodal transportation, warehousing, and distribution services for coal products. It serves nylon and fertilizers manufacturers, refined oil manufacturers, and other chemical companies, as well as industrial users, and trading and retail customers. The company was incorporated in 2012 and is headquartered in Jiyuan, China. Henan Jinyuan Hydrogenated Chemicals Co., Ltd. operates as a subsidiary of Henan Jinma Energy Company Limited.
How the Company Makes MoneyHenan Jinyuan Hydrogenated Chemicals Co., Ltd. generates revenue primarily through the sale of its hydrogenated chemical products. The company's key revenue streams include direct sales to industrial clients in sectors like pharmaceuticals and agrochemicals, as well as distribution partnerships that help expand its market reach. Additionally, Henan Jinyuan may engage in strategic collaborations or joint ventures to enhance its product offerings and access new markets, thereby contributing to its earnings.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Financial Statement Overview

Summary
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. shows mixed financial performance. Revenue growth is positive, but profitability and net income have declined, impacting overall financial health. The balance sheet remains stable with manageable debt levels, but cash flow management needs improvement to support sustainable growth.
Income Statement
55
Neutral
The company has experienced fluctuating revenue growth, with a recent increase of 33.1% from 2023 to 2024. However, profitability metrics such as gross profit margin (2.31%) and net profit margin (-0.52%) are weak, indicating challenges in cost management and profitability. The negative net income in 2024 highlights financial instability.
Balance Sheet
65
Positive
The balance sheet shows a moderate debt-to-equity ratio of 0.34, suggesting manageable leverage. The equity ratio is strong at 58.76%, indicating a solid equity base. However, the return on equity has turned negative, reflecting recent profitability issues.
Cash Flow
60
Neutral
Cash flow analysis reveals a positive operating cash flow to net income ratio of -6.04, indicating efficient cash generation despite net losses. Free cash flow has improved significantly, but the free cash flow to net income ratio remains negative due to the net loss.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.94B3.10B2.33B2.30B1.48B1.08B
Gross Profit22.36M71.64M148.80M285.51M142.80M91.41M
EBITDA29.36M77.03M163.47M294.84M168.50M115.65M
Net Income-66.50M-16.04M54.92M138.23M72.47M29.09M
Balance Sheet
Total Assets1.61B1.68B1.66B1.08B971.94M969.90M
Cash, Cash Equivalents and Short-Term Investments375.55M352.62M300.71M92.47M50.08M54.44M
Total Debt369.73M338.27M262.97M165.30M51.17M82.30M
Total Liabilities545.87M584.85M535.95M355.88M418.55M466.66M
Stockholders Equity965.11M985.37M1.02B573.79M457.93M400.56M
Cash Flow
Free Cash Flow-19.90M13.82M-43.95M199.74M44.27M-21.69M
Operating Cash Flow35.60M96.86M104.46M318.82M94.88M50.62M
Investing Cash Flow-222.25M-268.86M-71.06M-150.12M-58.70M-77.35M
Financing Cash Flow-43.37M2.49M204.95M-139.06M-44.28M12.71M

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.40
Price Trends
50DMA
0.47
Negative
100DMA
0.44
Negative
200DMA
0.42
Negative
Market Momentum
MACD
-0.03
Positive
RSI
39.30
Neutral
STOCH
46.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2502, the sentiment is Negative. The current price of 0.4 is below the 20-day moving average (MA) of 0.41, below the 50-day MA of 0.47, and below the 200-day MA of 0.42, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 39.30 is Neutral, neither overbought nor oversold. The STOCH value of 46.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2502.

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$1.04B8.003.36%8.15%-5.37%25.20%
68
Neutral
HK$220.80M12.117.30%2.17%29.04%-1.55%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
53
Neutral
HK$742.28M55.38-1.52%5.63%0.37%-331.54%
52
Neutral
HK$635.50M7.33-6.64%5.78%2.76%-293.57%
46
Neutral
HK$588.07M-14.53%0.35%-153.95%
39
Underperform
HK$62.77M-15.10%31.07%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2502
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H
0.40
-0.21
-34.43%
HK:0408
Yip's Chemical Holdings
1.84
0.35
23.74%
HK:1986
Tsaker New Energy Tech Co., Limited
0.77
-0.06
-7.23%
HK:2116
Jiangsu Innovative Ecological New Materials Ltd.
0.46
0.08
21.05%
HK:0301
SANVO Fine Chemicals Group Limited
1.25
0.41
48.81%
HK:0377
China Huajun Group Limited
0.98
0.25
34.25%

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H Corporate Events

Henan Jinyuan Reports Interim Loss Amidst Revenue Decline
Aug 26, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. reported its interim financial results for the first half of 2025, showing a revenue of RMB1,442.2 million and a loss attributable to owners of RMB20.2 million. The company experienced a decline in gross profit and a net loss for the period, indicating challenges in maintaining profitability amidst market conditions.

The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.

Henan Jinyuan Settles Taxes and Reduces Non-Aromatic Hydrocarbon Sales
Aug 8, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced that it has settled all relevant consumption taxes with the tax authorities by the end of June 2025, which were already accounted for in its 2024 financial results. Consequently, there is no financial impact on the company’s results for the first half of 2025. The company has significantly reduced its production and sales of non-aromatic hydrocarbons in the first half of 2025, anticipating a decrease in sales for the entire year compared to 2024, thus minimizing the financial impact of the consumption tax.

Henan Jinyuan Issues Profit Warning Amidst Declining Margins
Aug 8, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has issued a profit warning, indicating an expected loss of approximately RMB20.1 million for the first half of 2025. This downturn is attributed to a reduction in the gross profit margin of its main product, hydrogenated benzene-based chemicals, due to a price decrease that outpaced the reduction in raw material costs. The company advises caution for shareholders and potential investors as the financial results are yet to be finalized and audited.

Henan Jinyuan Hydrogenated Chemicals Announces Upcoming Board Meeting
Aug 8, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has announced a board meeting scheduled for August 26, 2025, to discuss and potentially approve the unaudited interim results for the first half of 2025 and consider the payment of an interim dividend. This meeting could have significant implications for the company’s financial performance and shareholder returns, as it will address key financial results and potential dividend distributions.

Henan Jinyuan Confirms No Change in Controlling Shareholder
Aug 5, 2025

Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced that there is no change in the shareholding of its controlling shareholder, Jinma Energy. Despite a termination notice served by Jinma Coking to Beijing Weigang regarding the sale of shares, Jinma Energy remains under the control of Mr. Yiu. This development is not expected to have any material impact on the financial position or operations of the company.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 03, 2025